Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 2
Submit an article Journal homepage
332
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification

Chia-Jen LiuDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;School of Medicine, National Yang-Ming University, Taipei, Taiwan
,
Ying-Chung HongDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;School of Medicine, National Yang-Ming University, Taipei, TaiwanCorrespondence[email protected]
,
Ching-Fen YangDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
,
Shih-Hao LiuDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;Department of Pathology and Laboratory Medicine, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan
,
Jyh-Pyng GauDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;School of Medicine, National Yang-Ming University, Taipei, Taiwan
,
Jin-Hwang LiuDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;School of Medicine, National Yang-Ming University, Taipei, Taiwan
,
Liang-Tsai HsiaoDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;School of Medicine, National Yang-Ming University, Taipei, Taiwan
,
Chun-Yu LiuDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;School of Medicine, National Yang-Ming University, Taipei, Taiwan
,
Yuan-Bin YuDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;School of Medicine, National Yang-Ming University, Taipei, Taiwan
&
Cheng-Hwai TzengDivision of Hematology and Oncology, Department of Medicine, Taipei, Taiwan;School of Medicine, National Yang-Ming University, Taipei, Taiwan
 show all
Pages 289-294 | Received 06 Feb 2011, Accepted 20 Jul 2011, Published online: 23 Sep 2011

References

  • Copelli M. Di una emopatia sistemizzata rapresentata da una imperplasia eritroblastica (eritromatosi). Pathologica 1912;4:460–465.
  • Di Guglielmo G. Richerche di ematologica. Folia Med 1917;3: 386–396.
  • Dameshek W, Baldini M. The Di Guglielmo syndrome. Blood 1958;13:192–194.
  • Bennett JM, Catovsky D, Daniel MT, . Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451–458.
  • Bennett JM, Catovsky D, Daniel MT, . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620–625.
  • Arber A, Brunning RD, Orazi A, . Acute myeloid leukaemia, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, . WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp 134–136.
  • Hasserjian RP, Zuo Z, Garcia C, . Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood 2010;115:1985–1992.
  • Lessard M, Struski S, Leymarie V, . Cytogenetic study of 75 erythroleukemias. Cancer Genet Cytogenet 2005;163:113–122.
  • Atkinson J, Hrisinko MA, Weil SC. Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature. Blood Rev 1992;6:204–214.
  • Davey FR, Abraham N Jr, Brunetto VL, . Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study. Am J Hematol 1995;49:29–38.
  • Goasguen JE, Matsuo T, Cox C, . Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival. Leukemia 1992;6:520–525.
  • Greenberg P, Cox C, LeBeau MM, . International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079–2088.
  • Grimwade D, Walker H, Oliver F, . The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92:2322–2333.
  • Breems DA, Van Putten WL, De Greef GE, . Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008;26:4791–4797.
  • Fernandez HF, Sun Z, Yao X, . Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med 2009;361:1249–1259.
  • Lowenberg B, Ossenkoppele GJ, van Putten W, . High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 2009;361:1235–1248.
  • Kern W, Estey EH. High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: review of three randomized trials. Cancer 2006;107:116–124.
  • Fenaux P, Mufti GJ, Hellstrom-Lindberg E, . Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009;10:223–232.
  • Cashen AF, Schiller GJ, O'Donnell MR, . Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. J Clin Oncol 2010;28:556–561.
  • Burnett AK, Milligan D, Prentice AG, . A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer 2007;109:1114–1124.
  • Park S, Picard F, Dreyfus F. Erythroleukemia: a need for a new definition. Leukemia 2002;16:1399–1401.
  • Colita A, Belhabri A, Chelghoum Y, . Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: a retrospective study of 54 cases. Ann Oncol 2001;12:451–455.
  • Olopade OI, Thangavelu M, Larson RA, . Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 1992;80:2873–2882.
  • Domingo-Claros A, Larriba I, Rozman M, . Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica 2002;87:148–153.
  • Gotze K, Platzbecker U, Giagounidis A, . Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group. Ann Hematol 2010;89:841–850.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.